The MarketWatch News Department was not involved in the creation of this content. bioAffinity Technologies' noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to ...
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
AZmed, one of the leading companies in artificial intelligence (AI) for radiology, announced today the CE marking of AZnod, ...
Multi-centre clinical study of cell-free DNA mutations in benign and malignant lung lesions. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a full ...
Perceptions about lung cancer have long been shaped by the prevalence of smoking as a heavy predictor of disease, but doctors have grown increasingly concerned about a growing number of cancer cases ...
Lung-RADS in clinical practice achieved excellent performance for lung cancer risk assessment on follow-up screening CT examinations, although strict application did downgrade some malignancies Noting ...
Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show a small white spot in the center of your lungs—a pulmonary or lung ...
Benign lung nodules can have a few different causes. These include current and past infections in the lungs and inflammation in the body from a condition like rheumatoid arthritis. A lung nodule is a ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback